$30.50
0.361.19%
Last update: Nov 5, 7:59 PM
Vera Therapeutics Inc
VERANASDAQ
Vera Therapeutics (VERA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.64 | $-1.59 | $-1.35 | $-1.30 |
| Actual | $-1.30 | $-1.52 | $-1.69 | $-1.39 |
| Surprise | +20.7% | +4.40% | -25.2% | -6.92% |
| Revenue | ||||
| Estimate | $3.2M | — | — | — |
| Actual | $10.3M | $0 | $0 | $0 |
| Surprise | +222.9% | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.55 | $-1.35 | $-1.21 | $-1.04 |
| Revenue | ||||
| Consensus | $15.7M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.30 | $-1.64 | 20.7 % |
| Q2 | Aug 10, 2026 | $-1.52 | $-1.59 | 4.40 % |
| Q1 | May 7, 2026 | $-1.69 | $-1.35 | -25.2 % |
| Q4 | Feb 26, 2026 | $-1.39 | $-1.30 | -6.92 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $10.28M | $3.18M | 222.9 % |
